Murphy Middleton Hinkle & Parker’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $415K | Hold |
5,310
| – | – | 0.17% | 106 |
|
|
2026
Q1 | $460K | Sell |
5,310
-6,653
| -56% | -$637K | 0.21% | 96 |
|
|
2025
Q4 | $213K | Buy |
11,963
+6,653
| +125% | +$646K | 0.1% | 126 |
|
|
2025
Q3 | $506K | Hold |
5,310
| – | – | 0.25% | 93 |
|
|
2025
Q2 | $477K | Hold |
5,310
| – | – | 0.27% | 92 |
|
|
2025
Q1 | $477K | Hold |
5,310
| – | – | 0.27% | 92 |
|
|
2024
Q4 | $424K | Sell |
5,310
-400
| -7% | -$34.6K | 0.24% | 97 |
|
|
2024
Q3 | $514K | Buy |
5,710
+400
| +8% | +$33.6K | 0.28% | 91 |
|
|
2024
Q2 | $418K | Sell |
5,310
-100
| -2% | -$8.2K | 0.24% | 97 |
|
|
2024
Q1 | $471K | Sell |
5,410
-412
| -7% | -$35.2K | 0.27% | 93 |
|
|
2023
Q4 | $480K | Sell |
5,822
-1,204
| -17% | -$91.8K | 0.3% | 86 |
|
|
2023
Q3 | $551K | Buy |
7,026
+400
| +6% | +$33.5K | 0.35% | 79 |
|
|
2023
Q2 | $584K | Sell |
6,626
-400
| -6% | -$34.4K | 0.36% | 80 |
|
|
2023
Q1 | $566K | Sell |
7,026
-100
| -1% | -$8.15K | 0.35% | 81 |
|
|
2022
Q4 | $554K | Buy |
7,126
+30
| +0.4% | +$2.43K | 0.35% | 84 |
|
|
2022
Q3 | $573K | Sell |
7,096
-95
| -1% | -$8.54K | 0.4% | 78 |
|
|
2022
Q2 | $645K | Hold |
7,191
| – | – | 0.42% | 77 |
|
|
2022
Q1 | $798K | Hold |
7,191
| – | – | 0.43% | 76 |
|
|
2021
Q4 | $744K | Hold |
7,191
| – | – | 0.4% | 76 |
|
|
2021
Q3 | $901K | Sell |
7,191
-265
| -4% | -$34.3K | 0.52% | 60 |
|
|
2021
Q2 | $926K | Hold |
7,456
| – | – | 0.52% | 62 |
|
|
2021
Q1 | $881K | Sell |
7,456
-40
| -0.5% | -$4.69K | 0.51% | 61 |
|
|
2020
Q4 | $878K | Sell |
7,496
-228
| -3% | -$25.1K | 0.58% | 56 |
|
|
2020
Q3 | $803K | Hold |
7,724
| – | – | 0.59% | 54 |
|
|
2020
Q2 | $708K | Hold |
7,724
| – | – | 0.52% | 58 |
|
|
2020
Q1 | $697K | Hold |
7,724
| – | – | 0.62% | 52 |
|
|
2019
Q4 | $876K | Hold |
7,724
| – | – | 0.58% | 58 |
|
|
2019
Q3 | $839K | Buy |
7,724
+1
| +0% | +$104 | 0.59% | 57 |
|
|
2019
Q2 | $752K | Sell |
7,723
-500
| -6% | -$45.7K | 0.54% | 62 |
|
|
2019
Q1 | $749K | Hold |
8,223
| – | – | 0.51% | 63 |
|
|
2018
Q4 | $748K | Sell |
8,223
-540
| -6% | -$50.5K | 0.57% | 55 |
|
|
2018
Q3 | $862K | Hold |
8,763
| – | – | 0.61% | 57 |
|
|
2018
Q2 | $750K | Hold |
8,763
| – | – | 0.56% | 59 |
|
|
2018
Q1 | $703K | Sell |
8,763
-1
| -0% | -$82 | 0.55% | 60 |
|
|
2017
Q4 | $708K | Buy |
+8,764
| New | +$702K | 0.53% | 59 |
|
Other funds holding MDT
LMFP
FWIA
DC
GI
MAA
CGH
CNB
Murphy Middleton Hinkle & Parker's MDT Position: Q2 2026 in Review
Murphy Middleton Hinkle & Parker held its Medtronic (MDT) position steady in Q2 2026 at 5,310 shares worth $415K. The position accounts for 0.17% of the portfolio, ranked #106.
Murphy Middleton Hinkle & Parker first reported a position in MDT in Q4 2017 and has held it in 35 quarters since. The position peaked at $926K in Q2 2021. 428 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Murphy Middleton Hinkle & Parker held 5,310 shares of Medtronic worth $415K as of Q2 2026.
- Murphy Middleton Hinkle & Parker left its Medtronic share count unchanged in Q2 2026.
- Medtronic made up 0.17% of Murphy Middleton Hinkle & Parker's portfolio in Q2 2026, its #106 holding.
- Murphy Middleton Hinkle & Parker first reported a position in Medtronic in Q4 2017 and has held it in 35 quarters since.
- Murphy Middleton Hinkle & Parker's Medtronic position peaked at $926K in Q2 2021.
- 428 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Murphy Middleton Hinkle & Parker's 13F filing for Q2 2026, filed 14 Jul 2026.